Back to Faculty Announcements

Hybrid lecture: "Assessing the Scientific Case for Early Phase Trials and/or Innovative Care: The PATH Approach"

Hybrid: Research Ethics & Policy Series (REPS)

January 10, 2024

Jonathan Kimmelman is a James McGill Professor in the Biomedical Ethics Unit / Social Studies of Medicine at McGill University, Montreal, QC. He has cross appointments in Experimental Medicine, Epidemiology, Biostatistics and Occupational Health, and Human Genetics. Kimmelman holds a PhD in Molecular Biophysics and Biochemistry from Yale University and joined McGill in 2005.
His research revolves around the ethical, social and policy dimensions of translational research.

Current projects are investigating risk, prediction, validity and knowledge value across the trajectory of drug development. Another set of projects is pursuing alternative frameworks and understandings concerning the role and content of clinical research ethics.

Location: B102AB Richards Building

Registration required:  Register REPS Kimmelman

Please send any questions to Lisa.Bailey@pennmedicine.upenn.edu